This article is more than 5 years old. Information may no longer be current.

VIDEO: Lesinurad offers gout patients a new choice

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

WASHINGTON — At the American College of Rheumatology Annual Meeting, Michael A. Becker, MD, professor emeritus in the Department of Medicine, Section of Rheumatology at the University of Chicago, reviewed his study of lesinurad, a new selective uric reabsorption inhibitor for the treatment of hyperuricemia in patients with gout.

He said when patients do not reach a sub-saturating level of urate with a xanthium oxidase inhibitor alone, then the choice is to either increase the dose of the inhibitor or add lesinurad.